Ads
related to: best med for sleep apnea treatmentexplorefrog.com has been visited by 10K+ users in the past month
sidekickbird.com has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.
The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly's Zepbound ...
Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, although it is not a cure and requires weight loss to be maintained over time.
Certain patients with obstructive sleep apnea who are deemed eligible candidates may be offered the hypoglossal nerve stimulator as an alternative. FDA-approved hypoglossal nerve neurostimulation is considered medically reasonable and necessary for the treatment of moderate to severe obstructive sleep apnea when all of the following criteria are met: [4]
In clinical trials, GLP-1 drug tirzepatide reduced sleep apnea events by as much as two-thirds over the course of 52 weeks in patients with obstructive sleep apnea. Patients taking a placebo ...
Without treatment, the sleep deprivation and lack of oxygen caused by sleep apnea increases health risks such as cardiovascular disease, aortic disease (e.g. aortic aneurysm), [165] high blood pressure, [166] [167] stroke, [168] diabetes, clinical depression, [169] weight gain, obesity, [66] and even death.
Ads
related to: best med for sleep apnea treatmentexplorefrog.com has been visited by 10K+ users in the past month
sidekickbird.com has been visited by 100K+ users in the past month